{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:22:30Z","timestamp":1770078150667,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Gout is a chronic inflammatory disease the development of which is associated with obesity-induced metabolic abnormalities. However, a substantial number of non-obese patients (body mass index [BMI] &lt;25\u00a0kg\/m<jats:sup>2<\/jats:sup>) also develop gout in Korea. It was suggested that accumulation of visceral fat rather than subcutaneous fat is associated with metabolic abnormalities and hyperuricemia in patients with gout; therefore, we hypothesized that visceral fat accumulation was increased in non-obese gout patients.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>One hundred and three male patients with primary gout and 204 age-matched healthy controls who attended a health check-up examination were recruited after the review of medical charts. The visceral fat area (VFA) was measured using the bioelectrical impedance analysis (BIA) method, and a VFA &gt;100\u00a0cm<jats:sup>2<\/jats:sup> was defined as visceral fat obesity (VFO). The frequency of VFO was compared in patients and control groups. The frequencies of metabolic syndrome and related parameters were also investigated.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>BMI, waist circumference, total fat mass, serum triglycerides, and serum glucose levels were significantly greater in patients compared with controls. VFA and the prevalence of VFO was increased in gout patients compared with controls. There were positive correlations between VFA and serum triglyceride levels and serum glucose levels. Multivariate regression analysis revealed that VFO is an independent risk factor for gout (odds ratio 2.488, 95% confidence interval 1.041\u20134.435). In non-obese subgroup analyses (gout patients, <jats:italic>n<\/jats:italic>\u2009=\u200938; healthy controls, <jats:italic>n<\/jats:italic>\u2009=\u2009150), VFA (98.7\u2009\u00b1\u200919.3 vs. 91.0\u2009\u00b1\u200916.7, <jats:italic>P<\/jats:italic>\u2009=\u20090.016) and the frequency of VFO (47.4 vs. 27.3%, <jats:italic>P<\/jats:italic>\u2009=\u20090.017) remained significantly higher in gout patients. There was no difference in either BMI or total fat mass between patients and controls in the non-obese subgroup. The prevalence of metabolic syndrome in patients with gout was 31.7% (33\/104), compared with 13.2% (5\/38) in the non-obese subgroup according to modified ATP III criteria.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>VFO, measured using BIA, is observed more frequently in patients with primary gout compared with healthy controls, even in non-obese individuals. Therefore, VFO might more properly represent metabolic derangements in patients with gout than general obesity.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-015-0593-6","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T19:17:20Z","timestamp":1426619840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study"],"prefix":"10.1186","volume":"17","author":[{"given":"Jennifer","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Min","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Sun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Hee","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyeon","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Su","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"593_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010;375:318\u201328.","journal-title":"Lancet"},{"key":"593_CR2","first-page":"92","volume":"19","author":"M Cigolini","year":"1995","unstructured":"Cigolini M, Targher G, Tonoli M, Manara F, Muggeo M, De Sandre G. Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int J Obes Relat Metab Disord. 1995;19:92\u20136.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"593_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/S0026-0495(97)90210-9","volume":"46","author":"S Takahashi","year":"1997","unstructured":"Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997;46:1162\u20135.","journal-title":"Metabolism"},{"key":"593_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/0-306-46843-3_26","volume":"486","author":"S Takahashi","year":"2000","unstructured":"Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Hada T. Increased visceral fat accumulation in patients with primary gout. Adv Exp Med Biol. 2000;486:131\u20134.","journal-title":"Adv Exp Med Biol"},{"key":"593_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/meta.2001.21688","volume":"50","author":"S Takahashi","year":"2001","unstructured":"Takahashi S, Moriwaki Y, Tsutsumi Z, Yamakita J, Yamamoto T, Hada T. Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout. Metabolism. 2001;50:393\u20138.","journal-title":"Metabolism"},{"key":"593_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2169\/internalmedicine.47.0603","volume":"47","author":"S Tamba","year":"2008","unstructured":"Tamba S, Nishizawa H, Funahashi T, Okauchi Y, Ogawa T, Noguchi M, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese Men. Int Med. 2008;47:1175\u201380.","journal-title":"Int Med"},{"key":"593_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/15257770.2011.596499","volume":"30","author":"N Ichikawa","year":"2011","unstructured":"Ichikawa N, Taniguchi A, Urano W, Nakajima A, Yamanaka H. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids. 2011;30:1045\u201350.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"593_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3346\/jkms.2005.20.6.1029","volume":"20","author":"YH Rho","year":"2005","unstructured":"Rho YH, Choi SJ, Lee YH, Ji JD, Choi KM, Baik SH, et al. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci. 2005;20:1029\u201333.","journal-title":"J Korean Med Sci"},{"key":"593_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/15257771003738709","volume":"29","author":"JM Fraile","year":"2010","unstructured":"Fraile JM, Torres RJ, de Miguel ME, Martinez P, Lundelin KJ, Vazquez JJ, et al. Metabolic syndrome characteristics in gout patients. Nucleosides Nucleotides Nucleic Acids. 2010;29:325\u20139.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"593_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/RHU.0b013e3181c6802e","volume":"16","author":"T Inokuchi","year":"2010","unstructured":"Inokuchi T, Tsutsumi Z, Takahashi S, Ka T, Moriwaki Y, Yamamoto T. Increased frequency of metabolic syndrome and its individual metabolic abnormalities in Japanese patients with primary gout. J Clin Rheumatol. 2010;16:109\u201312.","journal-title":"J Clin Rheumatol"},{"key":"593_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00296-009-1304-x","volume":"31","author":"HG Yoo","year":"2011","unstructured":"Yoo HG, Lee SI, Chae HJ, Park SJ, Lee YC, Yoo WH. Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis. Rheumatol Int. 2011;31:485\u201391.","journal-title":"Rheumatol Int"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57:109\u201315.","journal-title":"Arthritis Rheum"},{"key":"593_CR13","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1185\/030079906X167651","volume":"23","author":"S Novak","year":"2007","unstructured":"Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin. 2007;23:623\u201330.","journal-title":"Curr Med Res Opin"},{"key":"593_CR14","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/rheumatology\/keq274","volume":"49","author":"HH Dao","year":"2010","unstructured":"Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford). 2010;49:2400\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"593_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-065X.2012.01145.x","volume":"249","author":"CJ Tack","year":"2012","unstructured":"Tack CJ, Stienstra R, Joosten LA, Netea MG. Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family. Immunol Rev. 2012;249:239\u201352.","journal-title":"Immunol Rev"},{"key":"593_CR16","unstructured":"Steering Committee of the WHO Western Pacific Region, IASO & IOTF. The Asia-Pacific perspective: Redefining obesity and its treatment. Australia, 2000."},{"key":"593_CR17","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/archinte.165.7.742","volume":"165","author":"HK Choi","year":"2005","unstructured":"Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;165:742\u20138.","journal-title":"Arch Intern Med"},{"key":"593_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"V Bhole","year":"2010","unstructured":"Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: Fifty-two-year follow-up of a prospective cohort. Arthritis Rheum. 2010;62:1069\u201376.","journal-title":"Arthritis Rheum"},{"key":"593_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0026-0495(98)90346-8","volume":"47","author":"F Matsuura","year":"1998","unstructured":"Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47:929\u201333.","journal-title":"Metabolism"},{"key":"593_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0026-0495(85)90025-3","volume":"34","author":"IH Fox","year":"1985","unstructured":"Fox IH, John D, DeBruyne S, Dwosh I, Marliss EB. Hyperuricemia and hypertriglyceridemia: metabolic basis for the association. Metabolism. 1985;34:741\u20136.","journal-title":"Metabolism"},{"key":"593_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","volume":"314","author":"E Maury","year":"2010","unstructured":"Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314:1\u201316.","journal-title":"Mol Cell Endocrinol"},{"key":"593_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1573399810602040367","volume":"2","author":"O Hamdy","year":"2006","unstructured":"Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367\u201373.","journal-title":"Curr Diabetes Rev"},{"key":"593_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.trsl.2009.08.003","volume":"155","author":"H He","year":"2010","unstructured":"He H, Ni Y, Chen J, Zhao Z, Zhong J, Liu D, et al. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010;155:71\u20137.","journal-title":"Transl Res"},{"key":"593_CR25","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62:3237\u201348.","journal-title":"Arthritis Rheum"},{"key":"593_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2011.10.011","volume":"15","author":"R Stienstra","year":"2012","unstructured":"Stienstra R, Tack CJ, Kanneganti TD, Joosten LA, Netea MG. The inflammasome puts obesity in the danger zone. Cell Metabol. 2012;15:10\u20138.","journal-title":"Cell Metabol"},{"key":"593_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/1756-185X.12007","volume":"15","author":"TA Gheita","year":"2012","unstructured":"Gheita TA, El-Fishawy HS, Nasrallah MM, Hussein H. Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions. Int J Rheum Dis. 2012;15:521\u20135.","journal-title":"Int J Rheum Dis"},{"key":"593_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.metabol.2007.06.030","volume":"56","author":"Z Zhao","year":"2007","unstructured":"Zhao Z, Nie H, He H, Yan Z, Liu D, Luo Z, et al. High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism. 2007;56:1612\u20139.","journal-title":"Metabolism"},{"key":"593_CR29","first-page":"42","volume":"58","author":"H Ogawa","year":"2011","unstructured":"Ogawa H, Fujitani K, Tsujinaka T, Imanishi K, Shirakata H, Kantani A, et al. InBody 720 as a new method of evaluating visceral obesity. Hepatogastroenterology. 2011;58:42\u20134.","journal-title":"Hepatogastroenterology"},{"key":"593_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2337\/diacare.28.2.451","volume":"28","author":"M Ryo","year":"2005","unstructured":"Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, et al. A new simple method for the measurement of visceral fat accumulation by bioelectrical impedance. Diabetes Care. 2005;28:451\u20133.","journal-title":"Diabetes Care"},{"key":"593_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000098481","volume":"68","author":"MG Shaikh","year":"2007","unstructured":"Shaikh MG, Crabtree NJ, Shaw NJ, Kirk JM. Body fat estimation using bioelectrical impedance. Hormone Res. 2007;68:8\u201310.","journal-title":"Hormone Res"},{"key":"593_CR32","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1038\/oby.2010.71","volume":"18","author":"LM Browning","year":"2010","unstructured":"Browning LM, Mugridge O, Chatfield MD, Dixon AK, Aitken SW, Joubert I, et al. Validity of a new abdominal bioelectrical impedance device to measure abdominal and visceral fat: comparison with MRI. Obesity (Silver Spring). 2010;18:2385\u201391.","journal-title":"Obesity (Silver Spring)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0593-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-015-0593-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0593-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-015-0593-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:34:10Z","timestamp":1728923650000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-015-0593-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1186\/s13075-015-0593-6","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]},"assertion":[{"value":"6 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}